lead poisoning. Abnormal lead level in blood
Conditions
Interventions
Intervention 1: Intervention group: In this study, the intervention group included the active ingredient of silymarin in the form of a Livergol produced by Gol-Daru Company receives 420 mg daily (thre
Treatment - Drugs
Placebo
Intervention group: In this study, the intervention group included the active ingredient of silymarin in the form of a Livergol produced by Gol-Daru Company receives 420 mg daily (three times every 14
Control group: A group that receives a pill similar to Livergel as a placebo.
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 18-60 years old blood lead level>10mcg/dl opium abuser
Exclusion criteria
Exclusion criteria: Age under 18 years Get other types of other antioxidants Gastrointestinal diseases, especially absorption disorders, which can affect the effective absorption of the drug History of heart, kidney, and liver disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood lead level. Timepoint: Blood lead level measurement before drug interventions and And three months after use of the medication. Method of measurement: Atomic absorption. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMojdeh Mohammadi
Hamedan University of Medical Sciences
Outcome results
None listed